Jorey Chernett holds 12.46% of Kazia Therapeutics (KZIA) ADS

Rhea-AI Filing Summary

Kazia Therapeutics Ltd ownership filing: Jorey Chernett reports beneficial ownership of 1,412,662 ADS, representing 12.46% of the American Depositary Shares as of February 19, 2026. The percent is calculated using 11,335,991 ADS outstanding as of December 11, 2025, per the issuer's prospectus.

The filing is an amendment to a previously reported Schedule 13G and lists the Reporting Person's principal business address in Bloomfield Hills, Michigan, and U.S. citizenship.

Insights

Corporate Governance Analyst

Holds a single-digit-plus stake that may attract attention from governance watchers.

The Schedule 13G/A amendment shows 1,412,662 ADS or 12.46% owned by Jorey Chernett as of February 19, 2026. The filing references 11,335,991 ADS outstanding as of December 11, 2025.

Ownership above 10% is a notable disclosure threshold; subsequent filings could show changes. Any governance impact depends on whether the stake is passive (Schedule 13G) versus active engagement, but the amendment itself does not state intent to act.

Equity Markets Specialist

Disclosure clarifies a substantial individual stake but does not indicate trading direction.

The amendment documents beneficial ownership and voting/dispositive power figures: sole voting power and sole dispositive power of 1,412,662 ADS, per the cover items. The filing cites the issuer prospectus for the ADS outstanding base.

Market impact will depend on future transactions; this filing provides a static ownership snapshot rather than transactional detail.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:09 PM Learn about SEC filing dates

FAQ

What stake does Jorey Chernett report in KZIA?

The filing reports 1,412,662 ADS beneficially owned, equal to 12.46% of the class. The percentage is calculated using 11,335,991 ADS outstanding as of December 11, 2025, per the issuer's prospectus.

What date is the ownership figure in the KZIA filing tied to?

The beneficial ownership count is stated as of February 19, 2026. The ADS outstanding base used for the percentage is from December 11, 2025, cited from the issuer's prospectus filed December 23, 2025.

Does the KZIA Schedule 13G/A show voting power for the reporting person?

Yes. The cover information lists sole voting power and sole dispositive power of 1,412,662 ADS for the Reporting Person. Shared voting and dispositive powers are shown as 0 in the excerpt.

Is the KZIA filing an initial report or an amendment?

This document is labeled Amendment No. 1 to a Schedule 13G, indicating it updates a prior filing. The amendment restates beneficial ownership and related cover-page items for the Reporting Person.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

KAZIA THERAPEUTICS LTD

(Name of Issuer)

American Depositary Shares

(Title of Class of Securities)

48669G105

(CUSIP Number)

02/18/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 48669G105

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,412,662.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,412,662.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,412,662.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.46 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KAZIA THERAPEUTICS LTD
(b)	Address of issuer's principal executive offices:
Item 2.
(a)	Name of person filing: Jorey Chernett (the "Reporting Person")
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
(c)	Citizenship: US.
(d)	Title of class of securities: American Depositary Shares
(e)	CUSIP No.: 48669G105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The aggregate percentage of American Depositary Shares ("ADS") owned by the Reporting Person is based upon 11,335,991 American Depository Shares outstanding as of December 11, 2025 (assuming all outstanding Ordinary Shares were represented by American Depository Shares), as disclosed in the Issuer's Prospectus filed pursuant to Rule 424(b)(3), filed with the U.S. Securities and Exchange Commission (the "SEC") on December 23, 2025. As of the close of business on February 19, 2026, the Reporting Person beneficially owned 1,412,662 ADS.
(b)	Percent of class: 12.46%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	02/20/2026